Skip to main content

Table 2 Characteristics of the included patients in this meta-analysis

From: Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis

Author

Year

Age

Sex(male%)

HBV DNA(log10)

HBeAg(+), %

ALT, U/L

CD4+T Cell/μl

Chen [15]

2017

42

55

5.02

NR

NR

NR

Chen [16]

2013

38

82

5.6

58.3

246

100

Gao [17]

2016

37

58.6

5.03

NR

NR

NR

He [18]

2015

39

64

5.02

NR

NR

NR

Jain [12]

2006

39

84.2

7.8

76

60

180

Li [13]

2016

36

82.8

3.59

25.8

29

200

Liu [19]

2017

31

59

NR

34.1

NR

NR

Luo [20]

2016

54

65

NR

15

NR

41

Min Zhou [21]

2016

36

51

NR

NR

NR

NR

Wang [14]

2016

29

0

3.83

29

NR

322

Yan Zhou [22]

2016

38

57.2

5.04

NR

NR

NR

  1. HBV DNA, HBeAg, ALT, and CD4+T cell were all expressed in mean. NR: not report